Saturday, January 31, 2009 4:35:08 PM
Thanks for the report!
I just sent an email to the following addresses associated with DNAPrint Genomics:
dnap@dnaprint.com, RGabriel@dnaprint.com, info@dnaprint.com, pharmacogenomics_info@dnaprint.com, webmaster@dnaprint.com, admin@dnaprint.com, forensics_info@dnaprint.com, genotyping_info@dnaprint.com
Excerpts from my email:
[-begin quotes-]
To whom it may concern at DNAPrint Genomics,
I apologize for sending this to so many of DNAG's email addresses, but I think these are urgent issues, I want to help, and we (other investors and I) are having trouble getting ahold of anyone at DNAPrint Genomics, recently.
FYI, a new investor (there appear to be a number of new DNAG investors, and new people interested in DNAG,) posted the following today:
Link to message:
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=35239985
[...]
Please note, I am still interested in helping with the sign outside (hopefully getting it up off the ground, and maybe a new sign made.) I'm also interested if I and/or other investors can do anything, to get the sequencing machine in the lab back up and running. (I left voicemail for DNAG about this, yesterday.)
Also, as I previously mentioned, I am interested in a private placement [...] I hope that, with the recently increased interest from investors, there may be enough interest, from enough investors with enough money, to help DNAPrint pull through this financing pinch, hopefully without falling victim to a hostile takeover, or forced to accept more financing on less than desireable terms.
Please email me, or call me on my cell phone. [...]
Sincerely, and best wishes,
Daniel Gannon (shareholder, and long-time defender of DNAG on certain message boards)
[-end quotes-]
I hope someone gets back to me soon. I last spoke to Sarah on the phone just a little over a week ago. With everything that DNAPrint Genomics has going for it, including valuable intellectual property in the Personalized Medicine space (a rapidly emerging field the Obama administration strongly supports,) their talent and expertise, and their track record of persistence and integrity, I think it's in the interest of investors like myself, to help DNAPrint Genomics get through the current financing pinch, so it can grow into its potential, which I consider to be massive.
P.S., this may represent another ray of hope:
"The Obama administration will soon announce a new economic strategy that would lower mortgage costs and extend credit to small businesses..."
Quoted from:
By Amy Hoak, MarketWatch
Last update: 11:53 a.m. EST Jan. 31, 2009
New Obama strategy could lower mortgage costs
http://www.marketwatch.com/news/story/New-Obama-strategy-could-lower/story.aspx?guid=%7B10B27760-59F9-49F8-894A-10D7773B466B%7D
(If clicking the above link, add the %7D to the end in the address bar, because that's supposed to be part of the link.)
Recessions, especially credit-centered ones like this one, often hit small businesses very hard. DNAPrint Genomics is no exception. I strongly believe that DNAPrint Genomics deserves to survive, and thrive. They've made it this far, and made some very noteworthy (and widely noted) progress in various areas -- it wouldn't make any sense to give up now. All of this is my opinion, of course, but I know I'm not alone in this conviction.
Daniel
Last Shot Hydration Drink Announced as Official Sponsor of Red River Athletic Conference • EQLB • Jun 20, 2024 2:38 PM
ATWEC Announces Major Acquisition and Lays Out Strategic Growth Plans • ATWT • Jun 20, 2024 7:09 AM
North Bay Resources Announces Composite Assays of 0.53 and 0.44 Troy Ounces per Ton Gold in Trenches B + C at Fran Gold, British Columbia • NBRI • Jun 18, 2024 9:18 AM
VAYK Assembling New Management Team for $64 Billion Domestic Market • VAYK • Jun 18, 2024 9:00 AM
Fifty 1 Labs, Inc Announces Acquisition of Drago Knives, LLC • CAFI • Jun 18, 2024 8:45 AM
Hydromer Announces Attainment of ISO 13485 Certification • HYDI • Jun 17, 2024 9:22 AM